Scholarlink

<p>Duplications in the dystrophin gene (<i>DMD</i>) represent a common genetic variation associated with the onset of Duchenne and Becker muscular dystrophy. In this study, we reported a novel mRNA-derived <i>DMD</i> duplication identified by next-generation sequencing (NGS)-based expanded carrier screening (ECS) in a pregnant woman, which was not accurately detected by multiplex ligation probe amplification (MLPA) testing. The discrepancy was elucidated through the analysis of the duplication breakpoint via additional validation experiments. This variation was confirmed to originate from a partially reverse-transcribed intronless cDNA copy of a rare <i>DMD</i> gene transcript mRNA and reinserted into a noncoding region of chromosome 13. The variation was classified as benign because the <i>DMD</i> gene remained intact. We strongly recommend analysing the breakpoints before the pathogenicity assessment of <i>DMD</i> duplication variations, identified in ECS to improve the accuracy of clinical prediction and genetic counselling.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A novel partial mRNA-derived duplication of the DMD gene identified in NGS carrier screening

  • 期刊论文

  • 发表日期：

    2025年9月12日

查看全文
  • Xue Zhang,
  • Gang Wang,
  • Yuan Wan,
  • Yanling Dong,
  • Daru Lu,
  • Bo Tan

摘要

Duplications in the dystrophin gene (DMD) represent a common genetic variation associated with the onset of Duchenne and Becker muscular dystrophy. In this study, we reported a novel mRNA-derived DMD duplication identified by next-generation sequencing (NGS)-based expanded carrier screening (ECS) in a pregnant woman, which was not accurately detected by multiplex ligation probe amplification (MLPA) testing. The discrepancy was elucidated through the analysis of the duplication breakpoint via additional validation experiments. This variation was confirmed to originate from a partially reverse-transcribed intronless cDNA copy of a rare DMD gene transcript mRNA and reinserted into a noncoding region of chromosome 13. The variation was classified as benign because the DMD gene remained intact. We strongly recommend analysing the breakpoints before the pathogenicity assessment of DMD duplication variations, identified in ECS to improve the accuracy of clinical prediction and genetic counselling.